MANAGEMENT OF THROMBOSIS IN ANTIPHOSPHOLIPID ANTIBODY SYNDROME
- 1 August 2001
- journal article
- review article
- Published by Elsevier in Rheumatic Disease Clinics of North America
- Vol. 27 (3) , 633-642
- https://doi.org/10.1016/s0889-857x(05)70225-8
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Streptokinase in Acute Ischemic Stroke: An Individual Patient Data Meta-AnalysisStroke, 2000
- The Risk of Recurrent Deep Venous Thrombosis among Heterozygous Carriers of Both Factor V Leiden and the G20210A Prothrombin MutationNew England Journal of Medicine, 1999
- Severe infections in plasmapheresis-treated systemic lupus erythematosusArthritis & Rheumatism, 1998
- Successful therapy with danazol in refractory autoimmune thrombocytopenia associated with rheumatic diseases.Rheumatology, 1997
- The Catastrophic Antiphospholipid Syndrome 1996: Acute Multi-Organ Failure Associated with Antiphospholipid Antibodies: A Review of 31 PatientsLupus, 1996
- Successful Treatment of Acute Myocardial Infarction by Thrombolytic Therapy in a Patient with Primary Antiphospholipid Antibody SyndromeCardiology, 1996
- Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagenThe Lancet, 1995
- Patients with antiphospholipid antibodies and venous thrombosis should receive long term anticoagulant treatment.Annals of the Rheumatic Diseases, 1993
- Anticardiolipin Antibodies and the Risk for Ischemic Stroke and Venous ThrombosisAnnals of Internal Medicine, 1992
- Successful thrombolytic therapy for acute myocardial infarction in a patient with the antiphospholipid antibody syndromeAmerican Heart Journal, 1991